Respiratory Care Devices Market to Undertake Strapping Growth During 2025
Respiratory care is for patients suffering from pulmonary-related diseases. The therapy includes oxygen cylinders, concentrators and conserving devices, nebulizers, suction machines, and aerosol systems. Currently, patients with respiratory tract diseases use different devices that could help them with the removal of mucus from the airways and improve pulmonary function.
Rapid urbanization and growing pollution levels, surge in tobacco smoking, increase in preterm births, and rise in respiratory diseases such as asthma, COPD, tuberculosis, and pneumonia are the major factors driving the Respiratory Care Devices Market. Moreover, rise in demand for modern technologies, increase in disposable income, and surge in demand for respiratory care devices in private hospitals and specialty clinics boost market growth. However, considerable underdiagnosed and undertreated population with respiratory disorders and high cost of respiratory care devices act as restraints of the market.
Request to View Brochure of Report -
Based on device type, the global respiratory care devices market can be segmented into four types: therapeutic devices, diagnostic devices, monitoring devices, and consumables & accessories. The therapeutic devices segment can be divided into ventilators, humidifiers, masks, pap devices, nebulizers, inhalers, oxygen concentrators, nitric oxide delivery units, and others. The diagnostic devices segment can be classified into spirometers, polysomnography (PSG) devices, peak flow meters, and other devices. The monitoring devices segment can be categorized into pulse oximeters, gas analyzers, and capnographs. The consumables & accessories segment can be divided into disposable masks, tracheostomy tubes, nasal cannulas, disposable resuscitators, and others. Therapeutic devices is anticipated to be the largest segment of the market due to rapid rise in respiratory diseases such as asthma and COPD because of high pollution levels.
In terms of indication, the global respiratory care devices market can be classified into asthma, COPD, sleep apnea, infectious lung diseases, and others. COPD is anticipated to be the fastest growing segment, as tobacco smoking is a key factor in the development and progression of COPD. According to WHO data (2004), there were 64 million patients suffering from COPD and an estimated 3 million succumbed to the disease. COPD is projected to be the third largest cause of death globally by 2030.
Based on end-user, the global respiratory care devices market can be categorized into hospitals & specialty clinics, ambulatory care, and home care. hospitals & specialty clinics is expected to be the largest segment due to modernization of hospital infrastructure, investment in premium priced respiratory devices by hospitals, and requirement of trained professionals to operate and handle respiratory devices used for the treatment.
Request to View ToC of Report -
In terms of region, the global respiratory care devices market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America was the largest market for respiratory drugs due to favorable reimbursement policies and improved diagnosis. However, Asia Pacific is the fastest growing market for respiratory care devices, with China and India developing as major markets for these devices due to growing pollution levels. India has the highest number of TB patients in the world. COPD is also rising in India accounting for 1 in 10 deaths.
Key players in the global respiratory care devices market are Philips Respronics, Smiths Medical, Inc., Hamilton Medical AG, Hill-Rom Holdings, Inc., ResMed, Inc., Becton, Dickinson and Company, Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare Ltd., Medline Industries, Inc., and Rotech Healthcare, Inc., among others
View Report -
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
You can edit or delete your press release Respiratory Care Devices Market to Undertake Strapping Growth During 2025 here
News-ID: 979340 • Views: 201
More Releases from Transparency Market Research
Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the
More Releases for COPD
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Asthma and COPD Drugs Market worth $50,359 Million by 2022
"The key players of the Global COPD and asthma drugs market are employing novel concepts and ideas to improve, manage and control asthma & COPD, and also enhance their profitability so as to gain a competitive edge over the other market players. Seretide/Advair, Symbicort, and Singular were leading brands and accounted for around one-fourth share in world COPD and asthma drugs market." Global Asthma and COPD Drugs Market was valued at
Alarming Prevalence of COPD to Propel Oxygen Therapy Devices Market
"Oxygen therapy equipment market driven by increasing urbanization and rising levels of air pollution." An intelligence report on the global oxygen therapy equipment market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Global Oxygen Therapy Equipment Market - Analysis By Product, Portability, Application, Region, Country: Opportunities and Forecast (2017- 2022) - By Product (Oxygen Concentrators, Liquid Oxygen Devices and Oxygen Cylinders), By Portability (Stationary, Portable Devices), By Application (COPD,
Asthma and COPD Drugs Market | Key Opportunities And Forecast 2024
The top five companies in the U.S. and China Asthma And Copd Drugs Market accounted for just under 64.0% in 2015, hinting at not just the consolidated nature of this industry but also at the immense competition among players. GlaxoSmithKline plc, Astrazeneca plc, Boehringer Ingelheim, Merck & Co. Inc., and Novartis AG currently enjoy the leading spots in the asthma and COPD drugs market. According to Transparency Market Research, the opportunity
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the